MGMT and glioblastoma: Additionally, VPA treatment did not result in a statistically significant overall survival benefit in either MGMT staining-positive or MGMT staining-negative patients (Supplementary Figure S3), although there appears to be a trend toward better survival in long-term VPA-treated MGMT staining-negative newly diagnosed GBM patients (Supplementary Figure S3E).